The AIM-listed medical, life science and tech business developer said it had begun the process of seeking suitable candidates
() said its chairman, Richard Mansell-Jones, as well as a non-executive director, Miroslaw Izienicki, have stepped down from the board with immediate effect.
The AIM-listed medical, life science and tech business developer said it had begun the process of seeking suitable candidates and would update shareholders accordingly.
Amphion’s chief executive, Richard C.E. Morgan, added: "Our team at Amphion remains confident in the futures of Motif Bio and Polarean Imaging, both now publically listed companies, as well as the future potential of FireStar Software.
“We believe that as our companies' progress, Amphion's shareholders will benefit in turn and we look forward to building on that base with new investment opportunities in the life-sciences sector."
The news follows the admission to AIM of Amphion’s partner company, Polarean Imaging PLC () on March 29.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
In exchange for publishing services rendered by the Company on behalf of Amphion Innovations PLC named herein, including the promotion by the Company of Amphion Innovations PLC in any Content on the Site, the Company...
FOR OUR FULL DISCLAIMER CLICK HERE